Back
Bristol Myers Squibb Co. Vs. Regencell Bioscience Holdings Ltd. Industry Stock Comparison
Buy
68
BMY
Bristol Myers Squibb Co.
Last Price:
$56.73
Seasonality Move:
12.83%
Buy
69
RGC
Regencell Bioscience Holdings Ltd.
Last Price:
$52.50
Seasonality Move:
69.73%
Buy
68
Bristol Myers Squibb Co. (BMY)
is a Buy
Is Bristol Myers Squibb Co. a Buy, Sell or Hold?
-
The current Bristol Myers Squibb Co. [BMY] share price is $54.42. The Score for BMY is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
BMY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Regencell Bioscience Holdings Ltd. (RGC)
is a Buy
Is Regencell Bioscience Holdings Ltd. a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings Ltd. [RGC] share price is $33.03. The Score for RGC is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
RGC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMY Stock Price Chart
What is Bristol Myers Squibb Co.'s stock price today?
-
The Bristol Myers Squibb Co. share price today is $54.42Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RGC Stock Price Chart
What is Regencell Bioscience Holdings Ltd.'s stock price today?
-
The Regencell Bioscience Holdings Ltd. share price today is $33.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing slight buying pressure.
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.22 | Buy |
| Relative Strength Index (14 RSI): | 63.09 | Buy |
| Chaikin Money Flow: | 8736173 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.07 - 54.59) | Buy |
| Bollinger Bands (100): | (44.37 - 51.17) | Buy |
RGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.1 | Buy |
| Relative Strength Index (14 RSI): | 76.42 | Buy |
| Chaikin Money Flow: | 521546 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.56 - 24.12) | Buy |
| Bollinger Bands (100): | (12.24 - 19.42) | Buy |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.07 | Buy |
| 20-day SMA: | 53.41 | Buy |
| 50-day SMA: | 49.68 | Buy |
| 200-day SMA: | 48.46 | Buy |
| 8-day EMA: | 53.89 | Buy |
| 20-day EMA: | 53.06 | Buy |
| 50-day EMA: | 50.68 | Buy |
| 200-day EMA: | 49.3 | Buy |
RGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.22 | Buy |
| 20-day SMA: | 20.7 | Buy |
| 50-day SMA: | 16.52 | Buy |
| 200-day SMA: | 14.01 | Buy |
| 8-day EMA: | 24.99 | Buy |
| 20-day EMA: | 21.47 | Buy |
| 50-day EMA: | 18.24 | Buy |
| 200-day EMA: | 13.59 | Buy |
Bristol Myers Squibb Co. Earnings Growth & BMY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.53 per share, and a decrease next year of $0.16 per share.
Regencell Bioscience Holdings Ltd. Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bristol Myers Squibb Co. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regencell Bioscience Holdings Ltd. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||